Poly(2-oxazoline) based micelles with high capacity for 3rd generation taxoids: preparation, in vitro and in vivo evaluation

Journal of Controlled Release : Official Journal of the Controlled Release Society
Zhijian HeRobert Luxenhofer

Abstract

The clinically and commercially successful taxanes, paclitaxel and docetaxel suffer from two major drawbacks, namely their very low aqueous solubility and the risk of developing resistance. Here, we present a method that overcomes both drawbacks in a very simple manner. We formulated 3rd generation taxoids, able to avoid common drug resistance mechanisms with doubly amphiphilic poly(2-oxazoline)s (POx), a safe and highly efficient polymer for the formulation of extremely hydrophobic drugs. We found excellent solubilization of different 3rd generation taxoids irrespective of the drug's chemical structures with essentially quantitative drug loading and final drug to polymer ratios around unity. The small, highly loaded micelles with a hydrodynamic diameter of less than 100nm are excellently suited for parenteral administration. Moreover, a selected formulation with the taxoid SB-T-1214 is about one to two orders of magnitude more active in vitro than paclitaxel in the multidrug resistant breast cancer cell line LCC6-MDR. In contrast, in wild-type LCC6, no difference was observed. Using a q4d×4 dosing regimen, we also found that POx/SB-T-1214 significantly inhibits the growth of LCC6-MDR orthotropic tumors, outperforming commercia...Continue Reading

References

Jan 10, 1998·Journal of Pharmaceutical Sciences·R T LigginsH M Burt
May 10, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Sang Cheon LeeSeo Young Jeong
Jun 3, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tae-You KimYung-Jue Bang
Dec 21, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K L Hennenfent, R Govindan
Apr 25, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Florian C GaertnerMarkus Essler
Oct 12, 2007·The New England Journal of Medicine·Daniel F HayesUNKNOWN Cancer and Leukemia Group B (CALGB) Investigators
Oct 24, 2007·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Myrra G CarstensWim E Hennink
Feb 15, 2008·Proceedings of the National Academy of Sciences of the United States of America·Frank GuOmid C Farokhzad
May 10, 2008·Journal of Medicinal Chemistry·Iwao OjimaRalph J Bernacki
Feb 26, 2009·Journal of Natural Products·Iwao Ojima, Manisha Das
May 5, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ho-Chul ShinGlen S Kwon
Mar 30, 2010·Biomaterials·Robert LuxenhoferAlexander V Kabanov
Sep 3, 2010·Nature Reviews. Drug Discovery·Matthew D GalskyWilliam K Oh
Oct 6, 2010·Proceedings of the National Academy of Sciences of the United States of America·Nagesh KolishettiOmid C Farokhzad
Apr 26, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Robert LuxenhoferAlexander V Kabanov
May 24, 2011·Journal of Materials Science. Materials in Medicine·Juraj KronekBarbara Mendrek
Jun 3, 2011·Molecular Pharmaceutics·Ho-Chul ShinGlen S Kwon
Jun 3, 2011·Proceedings of the National Academy of Sciences of the United States of America·Jason I HerschkowitzJeffrey M Rosen
Jun 12, 2012·Molecular Pharmaceutics·Yingchao HanAlexander V Kabanov
Aug 7, 2012·Macromolecular Rapid Communications·Robert LuxenhoferRainer Jordan
Aug 9, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Patrick J RobertsNorman E Sharpless
Oct 5, 2012·Macromolecular Rapid Communications·Ondrej SedlacekMartin Hruby
Nov 22, 2012·Proceedings of the National Academy of Sciences of the United States of America·Mia L HuangMichael D Ward
Aug 31, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Libo ZhangSylvain Baruchel
Sep 10, 2013·Movement Disorders : Official Journal of the Movement Disorder Society·Karen L Eskow JaunarajsRandall W Moreadith
Mar 29, 2014·Science Translational Medicine·Lauren M ZasadilBeth A Weaver
Jul 23, 2014·Bioorganic & Medicinal Chemistry·Ruth MatesanzJ Fernando Díaz

❮ Previous
Next ❯

Citations

Dec 27, 2015·Pharmacology & Therapeutics·Ying ZhaoGuanhua Du
Jan 13, 2016·Macromolecular Bioscience·Jonas F NawrothRobert Luxenhofer
Jun 27, 2015·ACS Nano·Samir MitragotriChenjie Xu
May 29, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Leonie WyffelsSteven Staelens
Jun 28, 2017·Biomacromolecules·Thomas LorsonRobert Luxenhofer
Jul 28, 2017·Journal of the American Chemical Society·Michael M LübtowRobert Luxenhofer
Jul 11, 2019·Chemistry : a European Journal·Michael M LübtowRobert Luxenhofer
Oct 11, 2019·International Journal of Molecular Sciences·Mizied FalahAnwar Rayan
Mar 21, 2016·Current Protocols in Pharmacology·Jerry UsaryCharles M Perou
May 11, 2018·Journal of Biomaterials Science. Polymer Edition·Feng SuYangsheng Chen
Apr 8, 2020·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Julia BlöhbaumJürgen Groll
Aug 7, 2020·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Marvin GrüneAnn-Christin Pöppler
Jul 4, 2018·Scientific Reports·Alice Rita SalgarellaLeonardo Ricotti
Aug 18, 2020·International Journal of Nanomedicine·Zhong WanHai Zhang
Jun 30, 2019·Science Advances·Vinicius M AlvesAlexander Kabanov
Sep 28, 2020·Advanced Drug Delivery Reviews·Duhyeong HwangAlexander V Kabanov
Feb 21, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·Balaram Ghosh, Swati Biswas
Apr 17, 2021·International Journal of Nanomedicine·Min XuJing Gao
Jul 22, 2021·European Journal of Drug Metabolism and Pharmacokinetics·Malik Salman HaiderRobert Luxenhofer
Feb 23, 2018·Journal of Natural Products·Iwao OjimaChangwei Wang
Jun 28, 2018·The Journal of Physical Chemistry. B·Aristeidis PapagiannopoulosJudith Elizabeth Houston
May 8, 2020·ACS Applied Materials & Interfaces·Malik Salman HaiderRobert Luxenhofer
Nov 5, 2021·Macromolecular Bioscience·Chengbin YangChih-Kuang Chen
Nov 23, 2021·Pharmaceutical Development and Technology·Roshan KatekarJiaur R Gayen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.